Abstract: The present invention relates to a composition which, in addition to caffeine, also contains dimethylglycine and/or a salt of dimethylglycine. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair, scalp and/or skin.

Abstract: The present invention relates to a topical composition comprising dimethylglycine and/or a salt of dimethylglycine and having a pH of 3.0 to 5.9. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair and/or skin.

Abstract: The present invention relates to a composition containing dimethylglycine and/or a salt of dimethylglycine. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair and scalp.

Abstract: The use of a non-steroidal anti-inflammatory drug for the treatment of nonproductive cough caused by viruses or bacteria and a combination of at least one non-steroidal anti-inflammatory drug with at least one antitussive in a formulation to treat coughs.

Abstract: The application describes surfactant-containing foams whose liquid phases exhibit yield points, the manufacture thereof, and packaged products that contain said foams.

Abstract: The use of a non-steroidal anti-inflammatory drug for the treatment of nonproductive cough caused by viruses or bacteria and a combination of at least one non-steroidal anti-inflammatory drug with at least one antitussive in a formulation to treat coughs.

Abstract: The invention relates to a cable gland (1) having a flange (3) and a plug-in part (2) suited for an operational connection to the flange (3). The plug-in part (2) comprises a locking sleeve (4), and a fastener (7) for a connector (8), said fastener being operatively connected to said locking sleeve by way of a control slide (10). The control slide (10) is configured such that a rotation of the locking sleeve (4) around the longitudinal axis (x) of the plug-in part (2) results in an axial displacement of the fastener (7) in a longitudinal direction.

Abstract: The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.

Abstract: The use of a non-steroidal anti-inflammatory drug for the treatment of nonproductive cough caused by viruses or bacteria and a combination of at least one non-steroidal anti-inflammatory drug with at least one antitussive in a formulation to treat coughs.

Abstract: The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.

Abstract: The present invention concerns a method for diagnosing liver fibrosis wherein two or more diagnostic markers are measured and the measurements are correlated by a mathematic algorithm characterized in that the diagnostic markers are selected from the group N-terminal procollagen III propeptide (PIIINP), Collagen IV, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1 and MMP-9/TIMP-1 complex. The algorithm can be used to predict the histological score of a liver biopsy.

Abstract: A method of radar measurement by transmitting and receiving radar signals with at least two spatially separated radar systems. The method further includes exchanging reference radar signals between the at least two radar systems to determine measurement-relevant parameters. Moreover, a determination of at least one of a relative phase relationship of the reference radar signals of the radar systems and a relative time position of time references of the radar systems is based on reference radar signals received. The instant abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.

Abstract: The present invention concerns a method for diagnosing liver fibrosis wherein two or more diagnostic markers are measured and the measurements are correlated by a mathematic algorithm characterized in that the diagnostic markers are selected from the group N-terminal procollagen III propeptide (PIIINP), Collagen IV/, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1 and MMP-9/TIMP complex. The algorithm can be used to predict the histological score of a liver biopsy.

Abstract: A signal distribution arrangement having a central signal source and a plurality of signal receivers located along a common path. Each of the signal receivers is coupled in communication with the signal source by a line arranged within the common path. To eliminate distortion of the signal due to outside interference sources, each of the lines is arranged within the common path so that it traverses the common path an odd number of times between the signal source and the receiver to which it is coupled, and traverses the common path an even number of times between the receiver to which it is coupled and the end of the common path. Within each segment of the common path, the relative propagation sensitivity of each line is controlled such that the product of the number of times the line traverses that segment multiplied the relative propagation sensitivity of the line is the same for all lines.

Abstract: A method of controlling an active antenna comprising a matrix of individual transmitting/receiving elements. Two optical frequencies are superposed to generate an optical beat signal in the microwave frequency range. After electrical/optical conversion the beat signal is fed with a defined phase and amplitude to the individual transmitting/receiving elements of the antenna.